NDC 0093-3239
Buprenorphine 7.5 ug per 1 h patch, extended release
On the label: Teva Pharmaceuticals USA, Inc..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Teva Pharmaceuticals USA, Inc. names for other drugs.
Recalls
- Sep 4, 2020 · Class II · Teva Pharmaceuticals USA
Failed Stability Specifications: Below specification result for buprenorphine release rate.
Lots: Lot # 190017, exp. 02/2021; 190161, exp. 08/2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buprenorphine: every company that makes it
- Form
- patch, extended release, transdermal
- Strength
- 7.5 ug per 1 h
- Approval
- ANDA ANDA204937
- On the market since
- Dec 27, 2021
- Package NDCs
0093-3239-40- Official label
- DailyMed (National Library of Medicine), updated May 12, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?